Drug or treatment
Futibatinib clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Futibatinib that are recruiting, at sites in 15 countries (most in United States (2), Australia (2), Japan (2)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 15Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Futibatinib and immunotherapy with chemo as first-line treatment for advanced biliary tract cancer | Phase 3 | Brisbane and 20 other locations | Recruiting | Jul 17, 2026 |
| Futibatinib plus chemo-immunotherapy for colorectal and other solid tumors | Phase 2 | Amberg and 9 other locations | Recruiting | Dec 9, 2024 |
| Combining futibatinib and durvalumab before bladder cancer surgery for patients who can't use cisplatin | Phase 2 | Ann Arbor, Michigan and 2 other locations | Recruiting | Feb 16, 2024 |
| Futibatinib treatment for advanced cholangiocarcinoma with FGFR2 gene changes | Phase 2 | La Jolla, California and 64 other locations | Recruiting | Feb 14, 2023 |
All recruiting trials (4)
-
Futibatinib and immunotherapy with chemo as first-line treatment for advanced biliary tract cancer
A first-line treatment test combines Futibatinib with Zimberelimab and Gemcitabine/Cisplatin to see if it improves survival in people with unresectable or advanced biliary tract cancer.
-
Futibatinib plus chemo-immunotherapy for colorectal and other solid tumors
This study tests whether adding the oral drug futibatinib to standard chemotherapy and the immunotherapy tislelizumab helps people with unresectable or metastatic colorectal cancer when given as first-line treatment.
-
Combining futibatinib and durvalumab before bladder cancer surgery for patients who can't use cisplatin
This study is testing if combining two drugs, futibatinib and durvalumab, before bladder cancer surgery can help patients who can't take cisplatin feel better and improve their chances of recovery.
-
Futibatinib treatment for advanced cholangiocarcinoma with FGFR2 gene changes
This study is testing if two different doses of a new drug called futibatinib can help people with advanced bile duct cancer that has specific gene changes feel better after other treatments.
Quick answers
How many clinical trials of Futibatinib are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (2 trials), Australia (2 trials), Japan (2 trials), South Korea (2 trials), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.